 |
|
Intraovarian vascular enhancement via stromal injection of platelet-derived growth factors: Exploring subsequent oocyte chromosomal status and in vitro fertilization outcomes
Samuel H. Wood, E. Scott Sills
Clin Exp Reprod Med. 2020;47(2):94-100. Published online 2020 May 29 DOI: https://doi.org/10.5653/cerm.2019.03405
|
|
Citations to this article as recorded by
 Intraovarian platelet-rich plasma injection: a potential path to genetic parenthood for women with low ovarian reserve
Nalini Kaul
International Journal of Reproduction, Contracepti.2025;[Epub] CrossRef Changes in Ovarian Functions Following Platelet-Rich Plasma (PRP) Injection and Its Impact on in Vitro Fertilisation (IVF) Treatment: A Pre-Post Research
Serap Simavlı, Emel Kiyak Caglayan, Ikbal Kaygusuz, Fatih Albayrak, Eray Caliskan
Clinical and Experimental Obstetrics & Gynecology.2025;[Epub] CrossRef Intraovarian condensed platelet cytokines for infertility and menopause—Mirage or miracle?
E. Scott Sills, Samuel H. Wood, Anthony P.H. Walsh
Biochimie.2023; 204: 41. CrossRef Population Dynamics, Plasma Cytokines and Platelet Centrifugation: Technical and Sociodemographic Aspects of ‘Ovarian Rejuvenation’
E. Scott Sills, Seang Lin Tan
Clinics and Practice.2023; 13(2): 435. CrossRef Discussion of field effects after intraovarian injection of autologous platelet-rich plasma
E. Scott Sills, Samuel H. Wood
Bulletin of the National Research Centre.2023;[Epub] CrossRef Effects and mechanisms of intrauterine chronic hypoxia on ovarian reserve function of zygotic rats
Yanyan Huang, Shanshan Su, Weiwen Luo, Huohu Zhong, Xiali Wang, Guorong Lyu
Scientific Reports.2023;[Epub] CrossRef Ovarian recovery via autologous platelet‐rich plasma: New benchmarks for condensed cytokine applications to reverse reproductive aging
E. Scott Sills
AGING MEDICINE.2022; 5(1): 63. CrossRef Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP)
Yigit Cakiroglu, Aysen Yuceturk, Ozge Karaosmanoglu, Sule Yildirim Kopuk, Zeynep Ece Utkan Korun, Nola Herlihy, Richard T. Scott, Bulent Tiras, Emre Seli
Aging.2022; 14(6): 2513. CrossRef Platelet-rich plasma: inconclusive evidence of reproductive outcomes in menopausal women
Mira H. Kheil, Reem Bahsoun, Fady I. Sharara
Journal of Assisted Reproduction and Genetics.2022; 39(9): 1987. CrossRef Why might ovarian rejuvenation fail? Decision analysis of variables impacting reproductive response after autologous platelet-rich plasma
E. Scott SILLS
Minerva Obstetrics and Gynecology.2022;[Epub] CrossRef Intraovarian platelet-rich plasma administration could improve blastocyst euploidy rates in women undergoing in vitro fertilization
Zaher Merhi, Serin Seckin, Marco Mouanness
Clinical and Experimental Reproductive Medicine.2022; 49(3): 210. CrossRef Ovarian Rejuvenation Using Autologous Platelet-Rich Plasma
Tuyen Kim Cat Vo, Yuka Tanaka, Kazuhiro Kawamura
Endocrines.2021; 2(1): 15. CrossRef Resumed ovarian function and pregnancy in early menopausal women by whole dimension subcortical ovarian administration of platelet-rich plasma and gonadotropins
Chao Chin Hsu, Isabel Hsu, Leonard Hsu, Yi Jen Chiu, Sonam Dorjee
Menopause.2021; 28(6): 660. CrossRef The Scientific and Cultural Journey to Ovarian Rejuvenation: Background, Barriers, and Beyond the Biological Clock
E. Scott Sills
Medicines.2021; 8(6): 29. CrossRef Appraisal of Experimental Methods to Manage Menopause and Infertility: Intraovarian Platelet-Rich Plasma vs. Condensed Platelet-Derived Cytokines
E. Sills, Samuel Wood
Medicina.2021; 58(1): 3. CrossRef Intraovarian insertion of autologous platelet growth factors as cell-free concentrate: Fertility recovery and first unassisted conception with term delivery at age over 40
E. Scott Sills, Natalie S. Rickers, Samuel H. Wood
International Journal of Reproductive BioMedicine .2020; 18(12): 1081. CrossRef
|